← Back to Search

Systems Analysis and Improvement Approach for HIV Service Delivery (SAIA-SSP-HIV Trial)

N/A
Recruiting
Led By Alexis M Roth, PhD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to assess if a strategy to improve HIV service delivery in US syringe services programs is effective and cost-efficient.

Who is the study for?
This trial is for organizations within the US, its territories, or Tribal Nations that run syringe service programs (SSPs) offering sterile syringes to drug users and have recently provided HIV counseling and testing. It's not specified who can't join.
What is being tested?
The study tests an organizational strategy called SAIA-HIV-SSP aimed at improving HIV services in SSPs. It compares this approach with usual implementation over a period of 21 months to see if it increases HIV testing rates and is cost-effective.
What are the potential side effects?
Since this trial focuses on implementing a service delivery strategy rather than a medical intervention, traditional side effects are not applicable.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Costing
Effectiveness
Sustained Effectiveness

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SAIA-SSP-HIVExperimental Treatment1 Intervention
SAIA-SSP-HIV is an intervention that facilitates an organizational, SSP-level analysis of the delivery of HIV services by assigning a trained SAIA specialist to apply tools and techniques and engage staff to define barriers, identify solutions, and evaluate their success in cycles until achieving desired change regarding HIV service delivery. The scientific premise of this RCT is that SAIA will effectively boost and extend HIV service delivery cascades within SSPs assigned to the SAIA-SSP-HIV intervention condition (relative to IAU). SAIA specialists will meet with SSP staff biweekly for the first 3 months and then once monthly for the remaining 9 months during the 12-month intervention period.
Group II: Implementation as usualActive Control1 Intervention
SSPs randomized to the IAU arm will not receive support from a SAIA specialist. Though many SSPs in the US already offer HIV services, the investigators are testing the ability of SAIA-SSP-HIV to optimize the delivery of HIV services within SSPs. As such, the IAU condition is characterized by the absence of SAIA-SSP-HIV with the goal of comparing whether SAIA-SSP-HIV improves SSPs' HIV service delivery cascades.

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,189 Previous Clinical Trials
1,587,841 Total Patients Enrolled
Drexel UniversityOTHER
155 Previous Clinical Trials
48,190 Total Patients Enrolled
RTI InternationalOTHER
197 Previous Clinical Trials
940,116 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,606 Previous Clinical Trials
3,329,932 Total Patients Enrolled
Alexis M Roth, PhDPrincipal InvestigatorDrexel University
Barrot H Lambdin, PhDPrincipal InvestigatorRTI International
~18 spots leftby Jun 2026